Irene De Santo

988 total citations
13 papers, 692 citations indexed

About

Irene De Santo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Irene De Santo has authored 13 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Irene De Santo's work include Advanced Breast Cancer Therapies (9 papers), Breast Cancer Treatment Studies (6 papers) and Cancer-related Molecular Pathways (5 papers). Irene De Santo is often cited by papers focused on Advanced Breast Cancer Therapies (9 papers), Breast Cancer Treatment Studies (6 papers) and Cancer-related Molecular Pathways (5 papers). Irene De Santo collaborates with scholars based in Italy, United States and Switzerland. Irene De Santo's co-authors include Mario Giuliano, Grazia Arpino, Sabino De Placido, Lucia Del Mastro, Michelino De Laurentiis, Fabio Puglisi, Amelia McCartney, Luca Malorni, Angelo Di Leo and Ilenia Migliaccio and has published in prestigious journals such as Clinical Cancer Research, Cancer Treatment Reviews and Cancers.

In The Last Decade

Irene De Santo

13 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irene De Santo Italy 9 394 342 213 169 80 13 692
Pierre Bohanes United States 16 592 1.5× 266 0.8× 205 1.0× 350 2.1× 51 0.6× 52 1.0k
Fangchao Zheng China 9 425 1.1× 278 0.8× 203 1.0× 272 1.6× 27 0.3× 33 800
Daniela Morales-Espinosa Spain 12 276 0.7× 190 0.6× 155 0.7× 206 1.2× 13 0.2× 25 534
G. Thomas Budd United States 14 451 1.1× 270 0.8× 136 0.6× 171 1.0× 40 0.5× 39 716
Ana Teresa Amaral Spain 13 206 0.5× 244 0.7× 150 0.7× 317 1.9× 25 0.3× 20 633
Elena Geuna Italy 16 367 0.9× 224 0.7× 130 0.6× 242 1.4× 24 0.3× 44 729
Stefano Sioletic Italy 14 241 0.6× 282 0.8× 110 0.5× 214 1.3× 29 0.4× 27 719
Zuzana Čierna Slovakia 18 420 1.1× 194 0.6× 237 1.1× 340 2.0× 34 0.4× 47 930
Moubin Lin China 16 413 1.0× 145 0.4× 218 1.0× 333 2.0× 25 0.3× 54 978
Yoshimasa Kosaka Japan 17 381 1.0× 162 0.5× 207 1.0× 362 2.1× 48 0.6× 46 805

Countries citing papers authored by Irene De Santo

Since Specialization
Citations

This map shows the geographic impact of Irene De Santo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene De Santo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene De Santo more than expected).

Fields of papers citing papers by Irene De Santo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene De Santo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene De Santo. The network helps show where Irene De Santo may publish in the future.

Co-authorship network of co-authors of Irene De Santo

This figure shows the co-authorship network connecting the top 25 collaborators of Irene De Santo. A scholar is included among the top collaborators of Irene De Santo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene De Santo. Irene De Santo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Oing, Christoph, Pasquale Rescigno, Francesca Carlino, et al.. (2024). PARP inhibitors in testicular germ cell tumors: what we know and what we are looking for. Frontiers in Genetics. 15. 1480417–1480417. 1 indexed citations
2.
Schettini, Francesco, Olga Martínez‐Sáez, Claudette Falato, et al.. (2023). Prognostic value of intrinsic subtypes in hormone-receptor-positive metastatic breast cancer: systematic review and meta-analysis. ESMO Open. 8(3). 101214–101214. 8 indexed citations
3.
McCartney, Amelia, Martina Bonechi, Francesca De Luca, et al.. (2020). Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial. Clinical Cancer Research. 26(9). 2131–2139. 37 indexed citations
4.
Schettini, Francesco, Irene De Santo, Carmen G. Rea, et al.. (2020). Palbociclib added to ongoing endocrine therapy for hormone receptor‑positive HER2‑negative metastatic breast cancer: A case report series. Molecular and Clinical Oncology. 12(5). 456–460. 1 indexed citations
5.
Rossi, Lorenzo, Amelia McCartney, Emanuela Risi, et al.. (2019). Cyclin-Dependent Kinase 4/6 Inhibitors in Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer. Clinical Breast Cancer. 19(6). 392–398. 11 indexed citations
6.
Conforti, Alessandro, Francesco Schettini, Roberta Vallone, et al.. (2019). Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analogues. The Breast Journal. 25(6). 1310–1311. 5 indexed citations
7.
Santoro, Ciro, Roberta Esposito, Maria Lembo, et al.. (2019). Strain-oriented strategy for guiding cardioprotection initiation of breast cancer patients experiencing cardiac dysfunction. European Heart Journal - Cardiovascular Imaging. 20(12). 1345–1352. 40 indexed citations
8.
Rossi, Lorenzo, Amelia McCartney, Irene De Santo, et al.. (2019). The optimal duration of adjuvant endocrine therapy in early luminal breast cancer: A concise review. Cancer Treatment Reviews. 74. 29–34. 15 indexed citations
9.
McCartney, Amelia, Ilenia Migliaccio, Martina Bonechi, et al.. (2019). Mechanisms of Resistance to CDK4/6 Inhibitors: Potential Implications and Biomarkers for Clinical Practice. Frontiers in Oncology. 9. 666–666. 114 indexed citations
10.
Santo, Irene De, Amelia McCartney, Ilenia Migliaccio, Angelo Di Leo, & Luca Malorni. (2019). The Emerging Role of ESR1 Mutations in Luminal Breast Cancer as a Prognostic and Predictive Biomarker of Response to Endocrine Therapy. Cancers. 11(12). 1894–1894. 54 indexed citations
11.
Gerratana, Lorenzo, Debora Basile, Giuseppe Buono, et al.. (2018). Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype. Cancer Treatment Reviews. 68. 102–110. 187 indexed citations
12.
Schettini, Francesco, Irene De Santo, Carmen G. Rea, et al.. (2018). CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors. Frontiers in Oncology. 8. 608–608. 158 indexed citations
13.
Pagano, Tiziana, Pasquale De Rosa, Roberta Vallone, et al.. (2017). Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study. Menopause The Journal of The North American Menopause Society. 25(6). 657–662. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026